The Lancet Regional Health - Southeast Asia

The Lancet Regional Health - Southeast Asia is a gold open access monthly journal launched in June 2022 by The Lancet Group and Elsevier, publishing research that advances clinical practice and health policy in Southeast Asia, with a 2025 Journal Impact Factor of 6.4.The Lancet Regional Health - Southeast Asia（《柳叶刀区域健康：东南亚》）是柳叶刀集团与爱思唯尔于 2022 年 6 月创办的金色开放获取月刊，发表推动东南亚临床实践与卫生政策进步的研究，2025 年影响因子为 6.4。

Scope

• The journal is part of the Lancet Group's global initiative to advocate for health-care quality and access in all regions of the world.本刊是柳叶刀集团倡导全球各地区医疗质量与可及性的全球行动的组成部分。
• It fosters the advance of clinical practice and health policy in Southeast Asia, with the ultimate goal of improving health outcomes.刊物致力于推动东南亚临床实践与卫生政策的进步，以改善健康结局为最终目标。
• The journal aspires to increase the quality of regional and national health research and publishes high-quality original research that advocates change in, or illuminates, clinical practice and health policy.本刊力求提升区域与国家层面卫生研究的质量，发表倡导变革或阐明临床实践与卫生政策的高质量原创研究。
• Relevant reviews, commentaries and opinion pieces are also considered, alongside articles, correspondence, health policy and viewpoint contributions.本刊亦考虑相关综述、评论与观点文章，以及通信、卫生政策与视点类稿件。
• Invited topics include infectious diseases, non-communicable diseases, child and adolescent health, maternal and reproductive health, mental health, universal health care and health systems.刊物关注的选题包括传染病、非传染性疾病、儿童与青少年健康、孕产与生殖健康、心理健康、全民健康覆盖与卫生体系等。
• As a member of the Lancet Regional Health family, it complements sister journals each covering one of the six WHO regions.作为柳叶刀区域健康（The Lancet Regional Health）系列期刊的一员，本刊与分别覆盖世卫组织六大区域的姊妹刊相互补充。

History

• The journal was launched in June 2022 with volume 1, and its founding editorial set out a new vision for a healthier Southeast Asia.本刊于 2022 年 6 月创刊并出版第 1 卷，创刊社论提出了迈向更健康东南亚的新愿景。^[1]
• It is one of the Lancet Regional Health family of titles, each devoted to one of the six WHO regions, within the Lancet Group's portfolio of regional, specialty and discovery science journals.本刊是柳叶刀区域健康系列刊物之一，该系列各刊分别专注于世卫组织六大区域之一，同属柳叶刀集团旗下区域、专科与发现科学期刊群。
• The journal published seven volumes in its launch year and has appeared monthly since, with twelve volumes a year from 2023 onwards, running from volume 44 to volume 55 in 2026.本刊创刊年出版 7 卷，此后按月出版，自 2023 年起每年 12 卷，2026 年出版第 44 至 55 卷。^[2]
• Its Journal Impact Factor was 6.2 in 2024 and 6.4 in 2025, and the journal ranks in the first quartile of the JCR Health Care Sciences and Services and Public, Environmental and Occupational Health categories.其影响因子 2024 年为 6.2、2025 年为 6.4，在 JCR 卫生保健科学与服务以及公共卫生、环境与职业健康两个学科中均位列第一区（Q1）。
• Handling is rapid: the journal reports a median of two days from submission to first decision, 48 days to a decision after review and 110 days to acceptance.稿件处理迅速：刊物报告从投稿到首次决定的中位数为 2 天，评审后决定 48 天，录用 110 天。^[3]
• The journal is fully open access, with an article publishing charge of USD 2650 and articles published under a CC BY-NC-ND licence.本刊为完全开放获取期刊，文章处理费为 2650 美元，论文以 CC BY-NC-ND 许可发表。^[4]

Editors

• The founding Editor-in-Chief is Shalini Garg, PhD, MPH, who is based in Chennai, India, completed her doctoral fellowship at the Sree Chitra Tirunal Institute for Medical Sciences and Technology, and holds a Master of Public Health from Mahatma Gandhi University.创刊主编为 Shalini Garg（PhD、MPH），常驻印度金奈，曾在印度斯里·奇特拉·蒂鲁纳尔医学科学与技术研究所完成博士研究，并获圣雄甘地大学公共卫生硕士学位。^[5]
• Before joining The Lancet Group as the founding Editor-in-Chief, Garg worked in academia and publishing, and her interests include public health, health promotion, epidemiology, chronic diseases and behavioural sciences.加入柳叶刀集团出任创刊主编前，Garg 曾在学术界与出版界工作，研究兴趣包括公共卫生、健康促进、流行病学、慢性病与行为科学。
• Senior Editors Apoorva Dharmendra and Bhavani Nivetha, both based in Chennai, support the journal, with expertise in child and adolescent psychiatry and in maternal and child health respectively.高级编辑 Apoorva Dharmendra 与 Bhavani Nivetha 均常驻金奈，分别擅长儿童与青少年精神病学以及妇女儿童健康领域。
• An International Advisory Board of key opinion leaders and researchers from around the world lends subject, academic and geographical advice to the editorial team on an ad hoc basis.刊物设有国际顾问委员会，由全球关键意见领袖与研究人员组成，按需就学科、学术与地域问题为编辑团队提供咨询。
• Board members have no formal involvement in content selection or any part of the peer review process, and submissions authored by board members are handled by the journal's editors under standard peer review processes.顾问委员会成员不参与内容遴选或同行评审的任何环节，其署名稿件由刊物编辑按标准同行评审流程处理。
• Following Lancet Group policy, manuscripts undergo single-anonymised peer review after internal editorial assessment, the Editor-in-Chief is the final arbiter of decisions, and the group's journals follow the ICMJE recommendations and the COPE code of conduct.按柳叶刀集团政策，稿件经编辑部内部评估后送单盲同行评审，主编为各项决定的最终裁定者；集团旗下期刊均遵循 ICMJE 建议与 COPE 行为准则。